OSTERWEIS CAPITAL MANAGEMENT INC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
OSTERWEIS CAPITAL MANAGEMENT INC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2021$3,663,000
-50.4%
55,140
-41.7%
0.20%
-47.4%
Q2 2021$7,385,000
+39.9%
94,660
+69.7%
0.38%
+31.9%
Q1 2021$5,277,000
-15.8%
55,790
+8.5%
0.29%
-23.0%
Q4 2020$6,268,000
+17.9%
51,440
-15.5%
0.37%
+4.2%
Q3 2020$5,317,000
+46.1%
60,860
+8.0%
0.36%
+36.0%
Q2 2020$3,640,00056,3500.26%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q2 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 3,037,042$236,950,0008.05%
MPM BioImpact LLC 269,186$21,002,0003.45%
Logos Global Management LP 400,000$31,208,0002.62%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 121,541$9,481,0002.50%
Orbimed Advisors 2,361,327$184,231,0001.86%
First Light Asset Management, LLC 395,825$30,882,0001.85%
SECTORAL ASSET MANAGEMENT INC 211,650$16,513,0001.34%
Nicholas Investment Partners, LP 224,876$17,545,0001.10%
DAFNA Capital Management LLC 47,852$3,733,0000.78%
Eventide Asset Management 578,000$45,096,0000.61%
View complete list of TURNING POINT THERAPEUTICS I shareholders